Xiaojie Wu

820 total citations · 1 hit paper
46 papers, 554 citations indexed

About

Xiaojie Wu is a scholar working on Strategy and Management, Molecular Biology and Surgery. According to data from OpenAlex, Xiaojie Wu has authored 46 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Strategy and Management, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Xiaojie Wu's work include Corporate Finance and Governance (6 papers), Entrepreneurship Studies and Influences (4 papers) and Corporate Social Responsibility Reporting (4 papers). Xiaojie Wu is often cited by papers focused on Corporate Finance and Governance (6 papers), Entrepreneurship Studies and Influences (4 papers) and Corporate Social Responsibility Reporting (4 papers). Xiaojie Wu collaborates with scholars based in China, United States and Canada. Xiaojie Wu's co-authors include Jungang Xie, Xi Zhong, Ge Ren, Vickie Coleman Gallagher, Ping Deng, Yang Liu, Junling Zhao, Yanhua Lu, Yan Yu and Yun Zhou and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaojie Wu

40 papers receiving 538 citations

Hit Papers

A predictive machine lear... 2025 2026 2025 5 10 15 20 25
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A predictive machine learning force-field framework for liquid electrolyte development
    2025 29 citations Sheng Gong, Zhenliang Mu et al. Nature Machine Intelligence profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojie Wu China 13 107 82 77 71 48 46 554
Fuli Chen China 14 76 0.7× 13 0.2× 85 1.1× 145 2.0× 23 0.5× 63 720
Xiaoyang Sun China 17 62 0.6× 15 0.2× 26 0.3× 176 2.5× 91 1.9× 62 933
Fatemeh Momeni Iran 15 31 0.3× 75 0.9× 144 1.9× 673 9.5× 74 1.5× 35 1.4k
Xing Yao China 16 55 0.5× 29 0.4× 82 1.1× 218 3.1× 24 0.5× 35 1.1k
Poonam Puri Canada 10 23 0.2× 81 1.0× 118 1.5× 68 1.0× 19 0.4× 56 626
Yina Zhang China 19 26 0.2× 34 0.4× 52 0.7× 438 6.2× 28 0.6× 51 1.0k
Domingo González Cuba 13 37 0.3× 14 0.2× 76 1.0× 60 0.8× 23 0.5× 28 427
Kevin McCusker United States 11 27 0.3× 35 0.4× 15 0.2× 50 0.7× 80 1.7× 33 624

Countries citing papers authored by Xiaojie Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaojie Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojie Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojie Wu more than expected).

Fields of papers citing papers by Xiaojie Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojie Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojie Wu. The network helps show where Xiaojie Wu may publish in the future.

Co-authorship network of co-authors of Xiaojie Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojie Wu. A scholar is included among the top collaborators of Xiaojie Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojie Wu. Xiaojie Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Xi, et al.. (2025). Doing bad under industry tournament incentives: evidence from corporate social irresponsibility in China. Baltic Journal of Management. 20(2). 230–247.
2.
3.
Gong, Sheng, Zhenliang Mu, Hongyi Wang, et al.. (2025). A predictive machine learning force-field framework for liquid electrolyte development. Nature Machine Intelligence. 7(4). 543–552. 29 indexed citations breakdown →
4.
Chen, Xiaomei, et al.. (2024). Looking into the past and forward: Antecedents, processes, and consequences of organizational category formation. Journal of Business Research. 186. 114962–114962. 1 indexed citations
5.
Wu, Xiaojie, et al.. (2024). Corporate Social Irresponsibility in Business: A Systematic Literature Review and Future Agenda. Management and Organization Review. 1–27. 7 indexed citations
6.
Huang, Zhiwei, Wenfang Li, Ruohao Zhang, et al.. (2024). Pharmacokinetic/pharma-codynamic study of pralurbactam (FL058) combined with meropenem in a neutropenic murine thigh infection model. Frontiers in Microbiology. 15. 1516979–1516979.
7.
Wu, Xiaojie, et al.. (2023). The institutional logics perspective in management and organizational studies. Journal of Business Research. 167. 114183–114183. 13 indexed citations
8.
Wu, Xiaojie, et al.. (2023). Mucus hypersecretion in chronic obstructive pulmonary disease: From molecular mechanisms to treatment. Journal of Translational Internal Medicine. 11(4). 312–315. 6 indexed citations
9.
Cai, Li, Xun Li, Lan Qiu, et al.. (2023). Age at menarche and asthma onset among US girls and women: findings from NHANES, 2001–2018. Annals of Epidemiology. 87. 25–30.
10.
Li, Yi, Jufang Wu, Jicheng Yu, et al.. (2023). Population pharmacokinetics and exposure-safety of lipophilic conjugates prodrug DP-VPA in healthy Chinese subjects for dose regime exploring. European Journal of Pharmaceutics and Biopharmaceutics. 188. 153–160. 1 indexed citations
11.
Li, Yi, Kaoru Toyama, Hitoshi Ishizuka, et al.. (2023). Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study. Advances in Therapy. 40(4). 1628–1643. 4 indexed citations
12.
Wang, Shanshan, Yanjiao Lu, Zhen‐Li Huang, et al.. (2023). Sphingosine-1-Phosphate Receptor 4 Attenuates Neutrophilic Airway Inflammation in Experimental Asthma via Repressing Proinflammatory Macrophage Activation. International Journal of Biological Sciences. 19(5). 1597–1615. 13 indexed citations
13.
Wu, Xiaolong, Wenhao Li, Xiaojie Wu, et al.. (2022). OCT6 inhibits differentiation of porcine-induced pluripotent stem cells through MAPK and PI3K signaling regulation. 动物学研究. 43(6). 911–922. 7 indexed citations
14.
Zhong, Xi, Ge Ren, & Xiaojie Wu. (2021). Not all stakeholders are created equal: executive vertical pay disparity and firms’ choice of internal and external CSR. Review of Managerial Science. 16(8). 2495–2525. 26 indexed citations
15.
Deng, Ping, Yang Liu, Vickie Coleman Gallagher, & Xiaojie Wu. (2018). International strategies of emerging market multinationals: A dynamic capabilities perspective. Journal of Management & Organization. 26(4). 408–425. 55 indexed citations
16.
Huang, Xiji, Yun Zhou, Xiuqing Cui, et al.. (2018). Urinary polycyclic aromatic hydrocarbon metabolites and adult asthma: a case-control study. Scientific Reports. 8(1). 7658–7658. 25 indexed citations
17.
Liu, Yang, Ying Ying, & Xiaojie Wu. (2016). Catch‐up through Collaborative Innovation: Evidence from China. Thunderbird International Business Review. 59(4). 533–545. 18 indexed citations
18.
Huang, Xiji, Jungang Xie, Xiuqing Cui, et al.. (2016). Association between Concentrations of Metals in Urine and Adult Asthma: A Case-Control Study in Wuhan, China. PLoS ONE. 11(5). e0155818–e0155818. 48 indexed citations
19.
Shang, Jin, Junling Zhao, Junling Zhao, et al.. (2015). Interleukin-33 promotes inflammatory cytokine production in chronic airway inflammation. Biochemistry and Cell Biology. 93(4). 359–366. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fuli Chen Breakdown of academic impact, for papers by Xiaoyang Sun Breakdown of academic impact, for papers by Fatemeh Momeni Breakdown of academic impact, for papers by Xing Yao Breakdown of academic impact, for papers by Poonam Puri Breakdown of academic impact, for papers by Yina Zhang Breakdown of academic impact, for papers by Domingo González Breakdown of academic impact, for papers by Kevin McCusker
Rankless by CCL
2026